BioStack Platforms announced USD 9.5 million in Seed funding on 22 October 2026 from investors including Peak XV, Afore Capital, DCVC, Emerson Collective, SV Angel, Verdict Capital, Streamlined Ventures and Y Combinator. Cofounders Sanat Mishra and Parth Patwa are building clinical data infrastructure that connects fragmented hospital records across several countries. The platform creates privacy controlled, multimodal datasets for medical research, biotechnology and artificial intelligence development. BioStack says the financing will support United States and international expansion, technology development and team growth. The company reports access to more than 100 million deidentified patient records, a company supplied figure.
BioStack raises USD 9.5 million for medical AI data
A group including Peak XV and DCVC backs the Seed round.

Keep reading
More Funding

BrightAI secures USD 97 million to scale physical AI infrastructure
Smith Point Capital led the investment in sensor based monitoring for essential services.

Dcubed raises EUR 27.2 million to expand space hardware production
Warsaw Equity Group led the oversubscribed Series A plus round for the German manufacturer.

Linq raises USD 90 million to expand AI powered mobile infrastructure
Andreessen Horowitz led the Series B and partner Ben Horowitz joined the board.


